Literature DB >> 26704178

Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.

Alex M Helman1, M Paul Murphy2.   

Abstract

BACKGROUND: Vascular contributions to cognitive impairment and dementia (VCID) is a complex form of dementia, combining aspects of vascular disease and other forms of dementia, such as Alzheimer's disease. VCID encompasses a wide spectrum of cerebrovascular-driven cognitive impairment, from mild cognitive impairment to fully developed dementia. This disease state is further complicated by metabolic disorders, such as type 2 diabetes and hypertension, and lifestyle factors, like obesity and high fat diets. SCOPE OF REVIEW: This manuscript is meant to both define VCID and review the in vitro and in vivo models of the disease state. This includes in vitro models of the neurovascular unit, models of chronic cerebral hypoperfusion, animals with NOTCH3 mutations as a model of small vessel disease, large animals with cerebral amyloid angiopathy (CAA), and animal models of mixed dementia. MAJOR
CONCLUSIONS: Synthetic microvessels are a promising technique to study the neurovascular unit and canines, despite the cost, are an excellent model to study CAA. While there are several good models of individual aspects of VCID, the heterogeneity of the disease states prevents them from being a model of all aspects of the disease. Therefore, VCID needs to be further defined into disease states that exist within this umbrella term. This includes specific guidelines for stroke counts and stroke locations and further categorization of overlapping cerebrovascular and AD pathologies that contribute to dementia. This will allow for better models and a more thorough understanding of how vascular disease contributes to dementia. GENERAL SIGNIFICANCE: VCID is the second most common form of dementia and is expected to increase in coming years. The heterogeneity of VCID makes it difficult to study, but without better definitions and models, VCID presents a major public health problem for our aging population. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia, edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  VCI; VCID; Vascular cognitive impairment; Vascular contributions to cognitive impairment and dementia

Mesh:

Year:  2015        PMID: 26704178      PMCID: PMC4821780          DOI: 10.1016/j.bbadis.2015.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  136 in total

Review 1.  Homocysteine metabolism.

Authors:  J Selhub
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

2.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

3.  Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes.

Authors:  Yasuto Kido; Ikumi Tamai; Takeo Nakanishi; Toru Kagami; Iori Hirosawa; Yoshimichi Sai; Akira Tsuji
Journal:  Drug Metab Pharmacokinet       Date:  2002       Impact factor: 3.614

4.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

5.  CADASIL syndrome in a large Turkish kindred caused by the R90C mutation in the Notch3 receptor.

Authors:  U Utku; Y Celik; O Uyguner; M Yüksel-Apak; B Wollnik
Journal:  Eur J Neurol       Date:  2002-01       Impact factor: 6.089

6.  Linking Notch signaling to ischemic stroke.

Authors:  Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

7.  White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion.

Authors:  Masunari Shibata; Ryo Ohtani; Masafumi Ihara; Hidekazu Tomimoto
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

8.  Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study.

Authors:  Ge Li; Isaac C Rhew; Jane B Shofer; Walter A Kukull; John C S Breitner; Elaine Peskind; James D Bowen; Wayne McCormick; Linda Teri; Paul K Crane; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2007-08       Impact factor: 5.562

9.  Management and Prevention of Stroke Associated with Elevated Homocysteine.

Authors:  Peter J. Kelly; Karen L. Furie
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-10

Review 10.  Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.

Authors:  Raj N Kalaria
Journal:  Stroke       Date:  2012-08-09       Impact factor: 7.914

View more
  20 in total

1.  Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway.

Authors:  Leilei Mao; Tuo Yang; Xin Li; Xia Lei; Yang Sun; Yongfang Zhao; Wenting Zhang; Yanqin Gao; Baoliang Sun; Feng Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-13       Impact factor: 6.200

2.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

Review 3.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

Review 4.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

5.  Decreased parenchymal arteriolar tone uncouples vessel-to-neuronal communication in a mouse model of vascular cognitive impairment.

Authors:  Ki Jung Kim; Juan Ramiro Diaz; Jessica L Presa; P Robinson Muller; Michael W Brands; Mohammad B Khan; David C Hess; Ferdinand Althammer; Javier E Stern; Jessica A Filosa
Journal:  Geroscience       Date:  2021-01-07       Impact factor: 7.713

6.  Altered Neurovascular Coupling in Subcortical Ischemic Vascular Disease.

Authors:  Xiaoshuang Liu; Runtian Cheng; Li Chen; Junwei Gong; Tianyou Luo; Fajin Lv
Journal:  Front Aging Neurosci       Date:  2021-05-12       Impact factor: 5.750

Review 7.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

8.  Lipo‑prostaglandin E1 modifies cognitive impairment in rats with vascular cognitive impairment by promoting angiogenesis via the VEGF/VEGFR pathway.

Authors:  Bohui Liu; Suping Zhang; Xifeng Xiong; Li Ling; Rui He; Muzhen Wang; Wanqing Deng; Zhihe Liu; Yi Li
Journal:  Mol Med Rep       Date:  2017-07-14       Impact factor: 2.952

9.  Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia.

Authors:  Rosalba Siracusa; Daniela Impellizzeri; Marika Cordaro; Rosalia Crupi; Emanuela Esposito; Stefania Petrosino; Salvatore Cuzzocrea
Journal:  Front Neurol       Date:  2017-06-06       Impact factor: 4.003

Review 10.  Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease.

Authors:  Anna Chiarini; Ubaldo Armato; Daisong Liu; Ilaria Dal Prà
Journal:  Front Physiol       Date:  2016-04-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.